Loading
NASDAQHealthcareMedical - Specialties
Latest quote
$126.06
−$3.90 · -3.00%
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest quote
$126.06
−$3.90 · -3.00%
After-hours
$125.5
−$0.56 · -0.44%
Oct 8, 6:42 PM ET
Regular session · ET · Market data may be delayed.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Day range
Current $126.06
52-week range
Current $126.06
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
58
Fair Value
Sentiment
58
Mixed
Risk
48
Elevated Risk
Momentum
48
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Day range
Current $126.06
52-week range
Current $126.06
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 249.13M USD | 240.98M USD | 216.19M USD | 219.08M USD | 184.34M USD |
| Cost of goods sold | 90.86M USD | 90.11M USD | 82.94M USD | 85.39M USD | 75.25M USD |
| Gross profit | 158.27M USD | 150.87M USD | 133.25M USD | 133.69M USD | 109.09M USD |
| Research and development | 20.31M USD | 19.52M USD | 19.3M USD | 20.49M USD | 15.77M USD |
| Selling, general, and administrative | 119.45M USD | 115.02M USD | 111.49M USD | 109.88M USD | 88.62M USD |
| Operating expenses | 139.76M USD | 134.53M USD | 405.33M USD | 130.37M USD | 104.39M USD |
| Interest expense | 10.69M USD | 11.86M USD | 5.7M USD | 4.77M USD | 3.89M USD |
| Depreciation and amortization | 23.27M USD | 24.53M USD | 31.57M USD | 33.13M USD | 25.07M USD |
| Operating income | 18.51M USD | 16.34M USD | −272.08M USD | 3.32M USD | 4.7M USD |
| Net income | 6.71M USD | −1.97M USD | −254.25M USD | 930K USD | 1.87M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI21.55M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 ETFIWM18.69M0.02%78.56B USD0.19%$277.57-0.05%
Keeley Dividend ETFKDVD18.19M2.27%8M USD0.90%$27.63630.00%
Vanguard Extended Market ETFVXF8.2M0.01%95.4B USD0.05%$233.13-0.15%
Fidelity Enhanced Small Cap ETFFESM7.03M0.11%6.41B USD0.28%$45.25+0.07%
iShares Russell 2000 Growth ETFIWO6.59M0.05%14.25B USD0.24%$353.47-0.53%
Dimensional - US Targeted Value ETFDFAT5.52M0.02%30B USD0.33%$67.56+0.72%
Dimensional - US Small Cap ETFDFAS4.75M0.01%33.66B USD0.31%$78.10+0.23%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMKeeley Dividend ETFKDVDVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWODimensional - US Targeted Value ETFDFATDimensional - US Small Cap ETFDFASAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
